- Display 15 Products per page
Published: June 23, 2017 | Price: $400.00 – $800.00
Published: March 1, 2007 | Price: $450.00 – $2,990.00
Since the advent of LASIK nearly two decades ago, refractive vision correction remains a vibrant market impacted by technology. Kalorama's market analysis takes a look at the entire market for non-disease eye treatment procedures. Complete coverage of the vision correction market, including the correction of conditions such as myopia (nearsightedness), presbyobia (an inibility to focus), astigmatism and hyperopia or far-sightedness. Areas of the market covered in the report include: LASIK Equipment Sales Bladeless LASIK Spacers and RVC Alternatives Phakic...Published: June 1, 2012 | Price: $495.00 – $990.00
In February and March of 2012, Kalorama Information conducted a survey of 2,000 adults to ask them whether or not they would take a genetic test. This report, Consumer Testing and the Future of DTC Genetic Testing provides those results and compiles surveys from public and private sources to provide the following insights: Have Consumers Used a Self-Test Product? Would They Take a Genetic Test? Are They Concerned About Their Healthcare? What Diseases Are They Most Concerned About?...Published: February 26, 2015 | Price: $499.00 – $1,000.00
Implantable Infusion Pumps: World Market Analysis Implantable infusion pumps are designed to provide long-term drug infusion through intra-arterial, intravenou, subcutaneous, and epidural methods. They difficult to operate and least common among the infusion pump types. This provides a market opportunity. They are typically labeled for specific drugs, dosages, and routes of administration and require a high level of sophistication in the technology to run these pumps. For this reason market for implantable infusion pumps is limited to a handful of...Published: March 26, 2015 | Price: $499.00 – $1,000.00
Insulin Infusion Pumps: World Market Analysis Infusion pumps are used to infuse necessary fluids, including medications and/or nutrients, to a patient’s circulatory system. They delivere insulin precisely and continuously to ensure normal function. Insulin Infusion Pumps: World Market Analysis analyzes the present and future world market for these pumps, with market forecasts to 2019. Several leading competitors and product developers are listed in the manufacturer profiles. The profiled companies include: Animas Corporation/Johnson & Johnson Asante Solutions Cellnovo Insulet Corporation Medtronic...Published: April 17, 2015 | Price: $499.00 – $1,000.00
The Market for Clinical Chemistry Routine clinical chemistry comprises 30 to 40 tests of substrates, metabolites, electrolytes, blood gases, enzymes and lipids that can be organized into panels for specialty patient investigation and routine patient screening. Common specialty panels include those for renal clearance, liver function, and metabolic status. Clinical chemistries are performed on analyzers with varying levels of automation depending on the test volume run at a particular test site. The market for routine clinical chemistries can be segmented...Published: May 1, 2015 | Price: $499.00 – $1,000.00
As cardiovascular disease is the most common cause of mortality in the developed world, it is natural that a great deal of emphasis should be placed on devices used to treat advanced cardiovascular disease, particularly arrhythmias and congestive heart failure. This report, Cardiac Rhythm Device Markets, includes cardiac rhythm management devices with both external and internal applications. Major segments include defibrillators: electrical devices that deliver therapeutic levels of energy to the heart muscle for the treatment of ventricular defibrillation. pacemakers: small electrical...Published: May 15, 2015 | Price: $499.00 – $1,000.00
The Out-of-Pocket Healthcare Expenditures in the United States Out-of-pocket expenditures for health care products and services in the United States continue to rise and in 2015 represent a significant portion of consumers’ incomes. This is the result of a variety of factors including an aging U.S. population, rising utilization of medical products and services, and ongoing cutbacks to both public (federal and state) and private health coverage. Over the years, U.S. consumers’ annual out-of-pocket health care costs have risen from...Published: June 29, 2015 | Price: $499.00 – $1,000.00
The Market for Wearable Devices Fueled by an aging population with increasing healthcare needs, increasing use of outpatient care, advancing wireless technology capability, continuing nursing shortage, and ever-diminishing healthcare resources, the market for wearable medical devices has the potential for rapid growth. Use of wearable medical devices can improve care delivery and patient outcomes, reduce mortality rates, reduce hospital admissions, and result in more efficient use of healthcare resources. This Kalorama Information report, The Market for Wearable Medical Devices includes...Published: July 2, 2015 | Price: $499.00 – $1,000.00
Advanced Remote Patient Monitoring Systems, 8th Edition New patient monitoring systems are emerging in response to the increased healthcare needs of an aging population, new wireless technologies, better video and monitoring technologies, decreasing healthcare resources, an emphasis on reducing hospital days, and proven cost-effectiveness. This Kalorama Information report, Advanced Remote Patient Monitoring Systems, in its eighth edition, is a comprehensive study on the patient monitoring industry, including patient monitoring equipment and devices which have advanced features. The report specifically focuses...Published: July 8, 2015 | Price: $499.00 – $1,000.00
Mobile Health Device (mhealth) Markets Mobile health, or mHealth, can be loosely defined as the evaluation and delivery of healthcare using mobile and wireless devices. However, despite its simple description, the mHealth segment involves a complex and wide range of services, devices, software products, regulatory webs, market participants and end users. This complex framework requires the coordination of several parties and compatibility of several systems to provide a seamless network of health delivery. The process of mobile health involves using...Published: August 17, 2015 | Price: $499.00 – $1,000.00
What’s happening in biotechnology in the fastest-growing economies of the world? Who are the leaders operating in these nations and what partnerships have they completed? This report provides answers and informs readers of the companies they need to know about. Companies seeking new partners, companies to invest in or firms benchmarking competition will want to purchase this resource of today’s biotech market in the countries outside the United States and Europe. The report identifies eight important emerging company markets and...Published: August 24, 2015 | Price: $499.00 – $1,000.00
The Worldwide Market for Bioreactors The essential equipment needed for bioprocessing is the fermenter or bioreactor. Bioreactors are manufactured vessels or systems that support a biologically active environment, as cells require a very specific environment in which to grow. These bioreactors usually range in size from liters to cubic meters, and are often made of stainless steel for the large scale production of therapeutics. In the biopharmaceutical arena, smaller glass bioreactors usually are intended for research work and process development...Published: October 26, 2015 | Price: $499.00 – $1,000.00
Mergers and Acquisitions in the IVD Market Mergers and Acquisitions in the IVD Market documents some 240 acquisitions that have taken place from 2012 to October 2015 in the extremely dynamic IVD industry. And this is likely only a small portion of what is really happening in the market; more deals are still to come. In vitro diagnostic (IVD) companies have been very busy with respect to acquisitions in an attempt to augment market share in an increasingly competitive market....Published: June 1, 2007 | Price: $500.00 – $5,990.00
Multiple sclerosis (MS) is a chronic demyelinating CNS disease that causes significant disability in young adults and others. Worldwide, millions of people are affected by multiple sclerosis. Although there is no cure, approved treatments are available to slow the progression of MS and offer improved quality of life. Kalorama Information's: Multiple Sclerosis Treatments: World Market Outlook to 2011 is one of the few publications to take a detailed look at multiple sclerosis treatment market worldwide, as well as treatments that...